105 related articles for article (PubMed ID: 16481740)
1. Increased gene copy number of the transcription factor E2F1 in malignant melanoma.
Nelson MA; Reynolds SH; Rao UN; Goulet AC; Feng Y; Beas A; Honchak B; Averill J; Lowry DT; Senft JR; Jefferson AM; Johnson RC; Sargent LM
Cancer Biol Ther; 2006 Apr; 5(4):407-12. PubMed ID: 16481740
[TBL] [Abstract][Full Text] [Related]
2. E2F1 germline copy number variations and melanoma susceptibility.
Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
[TBL] [Abstract][Full Text] [Related]
3. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of ASK/Dbf4 in cutaneous melanoma is dependent on E2F1.
Nambiar S; Mirmohammadsadegh A; Hassan M; Hegemann JH; Hengge UR
Exp Dermatol; 2008 Dec; 17(12):986-91. PubMed ID: 18503552
[TBL] [Abstract][Full Text] [Related]
5. Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness.
Meng P; Bedolla RG; Yun H; Fitzpatrick JE; Kumar AP; Ghosh R
Mol Carcinog; 2019 Sep; 58(9):1701-1710. PubMed ID: 31124185
[TBL] [Abstract][Full Text] [Related]
6. E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation.
Knoll S; Fürst K; Kowtharapu B; Schmitz U; Marquardt S; Wolkenhauer O; Martin H; Pützer BM
EMBO Rep; 2014 Dec; 15(12):1315-29. PubMed ID: 25341426
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis signal-regulating Kinase 1 by E2F-1 may not be essential for E2F-1-mediated apoptosis in melanoma cells.
Dong YB; Phelps AM; Yang HL; Jamshidi-Parsian A; Chen C; Hao H; Gomez-Gutierrez JG; Zhou HS; McMasters KM
Tumour Biol; 2007; 28(2):111-22. PubMed ID: 17287612
[TBL] [Abstract][Full Text] [Related]
8. Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma.
Vardabasso C; Gaspar-Maia A; Hasson D; Pünzeler S; Valle-Garcia D; Straub T; Keilhauer EC; Strub T; Dong J; Panda T; Chung CY; Yao JL; Singh R; Segura MF; Fontanals-Cirera B; Verma A; Mann M; Hernando E; Hake SB; Bernstein E
Mol Cell; 2015 Jul; 59(1):75-88. PubMed ID: 26051178
[TBL] [Abstract][Full Text] [Related]
9. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
[TBL] [Abstract][Full Text] [Related]
10. Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping.
Sargent LM; Nelson MA; Lowry DT; Senft JR; Jefferson AM; Ariza ME; Reynolds SH
Genes Chromosomes Cancer; 2001 Sep; 32(1):18-25. PubMed ID: 11477657
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line.
Saito M; Helin K; Valentine MB; Griffith BB; Willman CL; Harlow E; Look AT
Genomics; 1995 Jan; 25(1):130-8. PubMed ID: 7774910
[TBL] [Abstract][Full Text] [Related]
12. Copy number variations of
Rocca MS; Di Nisio A; Marchiori A; Ghezzi M; Opocher G; Foresta C; Ferlin A
Endocr Relat Cancer; 2017 Mar; 24(3):119-125. PubMed ID: 28104681
[TBL] [Abstract][Full Text] [Related]
13. E2F1 in melanoma progression and metastasis.
Alla V; Engelmann D; Niemetz A; Pahnke J; Schmidt A; Kunz M; Emmrich S; Steder M; Koczan D; Pützer BM
J Natl Cancer Inst; 2010 Jan; 102(2):127-33. PubMed ID: 20026813
[TBL] [Abstract][Full Text] [Related]
14. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.
Okamoto I; Pirker C; Bilban M; Berger W; Losert D; Marosi C; Haas OA; Wolff K; Pehamberger H
Neoplasia; 2005 Apr; 7(4):303-11. PubMed ID: 15967107
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of E2F1 during ER stress is required to induce apoptosis.
Pagliarini V; Giglio P; Bernardoni P; De Zio D; Fimia GM; Piacentini M; Corazzari M
J Cell Sci; 2015 Mar; 128(6):1166-79. PubMed ID: 25616897
[TBL] [Abstract][Full Text] [Related]
16. KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.
Riverso M; Montagnani V; Stecca B
Oncogene; 2017 Jun; 36(23):3322-3333. PubMed ID: 28068326
[TBL] [Abstract][Full Text] [Related]
17. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma.
Barks JH; Thompson FH; Taetle R; Yang JM; Stone JF; Wymer JA; Khavari R; Guan XY; Trent JM; Pinkel D; Nelson MA
Genes Chromosomes Cancer; 1997 Aug; 19(4):278-85. PubMed ID: 9258664
[TBL] [Abstract][Full Text] [Related]
18. E2F1 Signalling is Predictive of Chemoresistance and Lymphogenic Metastasis in Penile Cancer: A Pilot Functional Study Reveals New Prognostic Biomarkers.
Fenner F; Goody D; Protzel C; Erbersdobler A; Richter C; Hartz JM; Naumann CM; Kalthoff H; Herchenröder O; Hakenberg OW; Pützer BM
Eur Urol Focus; 2018 Jul; 4(4):599-607. PubMed ID: 28753861
[TBL] [Abstract][Full Text] [Related]
19. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
20. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
